⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 1, 2013European Respiratory Journal

Tiotropium Respimat increases the risk of mortality: pro

Richard Beasley

View at Publisher

Ask AI

Bookmark

Share

Abstract

Tiotropium Respimat increases mortality risk. First do no harm. Tiotropium Respimat should not be prescribed in COPD

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Richard Beasley (2013) studied this question.

synapsesocial.com/papers/6aa2660c15b648e242139e2b https://doi.org/10.1183/09031936.00042113

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A new system for grading recommendations in evidence based guidelinesSystematic Review · 2001 · 1,637 citations
2Evidence based medicine: what it is and what it isn't1996 · 15,776 citations
3Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trialsRCT · 2011 · 226 citations
4Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trialsPrognostic Study · 2012 · 139 citations
5Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary DiseaseRCT · 2008 · 493 citations

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease2008
Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution.1988
The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma.1988
Muco-obstructive lung disease exhibits distinct hypoxic and inflammatory airway epithelial gene pathwaysEuropean Respiratory Journal · 2026
Don't discard the supernatant: pleural fluid cfDNA for molecular profiling in lung cancerEuropean Respiratory Journal · 2026

EMore from European Respiratory Journal

More from Medical Research Institute of New Zealand